share_log
Benzinga ·  Jun 13 16:16
Vaxart Shares Are Trading Higher After the Company Received a BARDA-funded Project NextGen Award Valued up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment